Rotavirus Vaccine Impact and Effectiveness Assessments

1159
Infectious Disease
Viral Diseases
infectious disease
Off
Rotavirus Vaccine Impact and Effectiveness Assessments
CDC's National Center for Immunization and Respiratory Diseases
GAVI
Burkina Faso
Democratic Republic of the Congo
/give
To ensure impact and effectiveness of rotavirus vaccines and sustain vaccine use by policy makers, physicians and parents to increase the speed of adoption of vaccine by other countries in Africa and around the world.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off
Rotavirus

Characterization of Non-Rotavirus Viral Diarrheal Pathogens

1146
Kathleen Jacobson
Infectious Disease
Viral Diseases
infectious disease
Off
Characterization of Non-Rotavirus Viral Diarrheal Pathogens
CDC's National Center for Immunization and Respiratory Diseases
Bill & Melinda Gates Foundation
United States of America
/give
To support the characterization of non-rotavirus viral diarrheal pathogens to inform the body of work that contributes to optimize the efficacy of rotavirus vaccines.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off
Infection Control

Origin of Innate Immunity Suppression

1140
Infectious Disease
Viral Diseases
infectious disease
Off
Origin of Innate Immunity Suppression
CDC's National Center for Emerging and Zoonotic Infectious Diseases
University of California, Riverside
United States of America
/give
To further research how viral ovarian tumor protease activity is critical for replication and host tropism of nairoviruses.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off
Infection Control

Mechanisms of Norovirus Protective Immunity

1121
Kathleen Jacobson
Infectious Disease
Viral Diseases
infectious disease
Off
Mechanisms of Norovirus Protective Immunity
CDC's National Center for Immunization and Respiratory Diseases
University of North Carolina at Chapel Hill
United States of America
/give
To screen a subset of human and mouse monoclonal antibodies for their ability to neutralize GI.1; a time ordered panel of GII.4; and GII.3 noroviruses using a novel human intestinal enteroid cell culture system.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off
Norovirus

Origin of the Innate Immunity Suppression Caused by Nairovirus' Protease

1115
Kathleen Jacobson
Infectious Disease
Viral Diseases
Norovirus
Off
Origin of the Innate Immunity Suppression Caused by Nairovirus' Protease
CDC's National Center for Emerging and Zoonotic Infectious Diseases
The University of Georgia
United States of America
/give
To further research how viral ovarian tumor protease (vOTU) activity is critical for replication and host tropism of nairoviruses.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off
Infection Control

Environmental Control of SARS-CoV-2 in Food Establishments

1126
Kathleen Jacobson
Infectious Disease
Viral Diseases
COVID protection
Off
Environmental Control of SARS-CoV-2 in Food Establishments
CDC's National Center for Immunization and Respiratory Diseases
University of Arkansas at Little Rock
United States of America
/give
To provide an evidence base for the food service industry to help navigate the COVID-19 pandemic.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off
Infection Control
Subscribe to Viral Diseases